These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33132272)

  • 21. Japan's healthcare policy for the elderly through the concepts of self-help (Ji-jo), mutual aid (Go-jo), social solidarity care (Kyo-jo), and governmental care (Ko-jo).
    Sudo K; Kobayashi J; Noda S; Fukuda Y; Takahashi K
    Biosci Trends; 2018 Mar; 12(1):7-11. PubMed ID: 29479017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healing an ailing pharmaceutical system: prescription for reform for United States and Canada.
    Gaffney A; Lexchin J; ;
    BMJ; 2018 May; 361():k1039. PubMed ID: 29773533
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary healthcare policy and vision for community pharmacy and pharmacists in the United States.
    Salgado TM; Rosenthal MM; Coe AB; Kaefer TN; Dixon DL; Farris KB
    Pharm Pract (Granada); 2020; 18(3):2160. PubMed ID: 33029264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [SETSUYAKU-BAG Campaign--investigation of outpatient's leftover drugs and promotion of proper reuse of leftover drugs to reduce medical expenses].
    Koyanagi K; Kubota T; Kobayashi D; Kihara T; Yoshida T; Miisho T; Saito Y; Uchigoshi H; Takaki J; Seo T; Shimazoe T
    Yakugaku Zasshi; 2013; 133(11):1215-21. PubMed ID: 23978848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canadian Health Care System: Who Should Pay for All Medically Beneficial Treatments? A Burning Issue.
    Chowdhury MZI; Chowdhury MA
    Int J Health Serv; 2018 Apr; 48(2):289-301. PubMed ID: 29095077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary health care policy and vision for community pharmacy and pharmacists in Australia.
    Dineen-Griffin S; Benrimoj SI; Garcia-Cardenas V
    Pharm Pract (Granada); 2020; 18(2):1967. PubMed ID: 32477437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current state of community pharmacy in Japan: practice, research, and future opportunities or challenges.
    Yamamura S; Yamamoto N; Oide S; Kitazawa S
    Ann Pharmacother; 2006 Nov; 40(11):2008-14. PubMed ID: 17062835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations.
    Perraudin C; Bugnon O; Pelletier-Fleury N
    Health Policy; 2016 Dec; 120(12):1350-1362. PubMed ID: 28228230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMCP Partnership Forum: Designing Benefits and Payment Models for Innovative High-Investment Medications.
    J Manag Care Spec Pharm; 2019 Feb; 25(2):156-162. PubMed ID: 30698091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What can the Canadians and Americans learn from each other's health care systems?
    Weil TP
    Int J Health Plann Manage; 2016 Jul; 31(3):349-70. PubMed ID: 27469581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conceptualising production, productivity and technology in pharmacy practice: a novel framework for policy, education and research.
    Baines D; Bates I; Bader L; Hale C; Schneider P
    Hum Resour Health; 2018 Oct; 16(1):51. PubMed ID: 30285766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection.
    J Manag Care Spec Pharm; 2020 Jan; 26(1):55-62. PubMed ID: 31880226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How Single-payer Stacks Up: Evaluating Different Models of Universal Health Coverage on Cost, Access, and Quality.
    Fox A; Poirier R
    Int J Health Serv; 2018 Jul; 48(3):568-585. PubMed ID: 29925286
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.